Intrinsiqs

Is Aura Biosciences, Inc. overvalued?

Aura Biosciences, Inc. (AURA) — key valuation metrics and fundamentals.

No verdict
Price
$6.15
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$636.1M
Dividend yield
0.0%
Return on equity
-73.2%
Sector
Healthcare

See the full interactive analysis →

Fair value compares AURA's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.